Nelson N. Stone, MD, presented “Artificial Intelligence and Extended Reality for Urology Training” during the 34th International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.

This content is available free to the GRU Community. Login or create an account to view it.


Create an Account

How to cite: Stone, Nelson N. Artificial Intelligence and Extended Reality for Urology Training.” February 2024. Accessed Jul 2024.

Artificial Intelligence and Extended Reality for Urology Training – Summary

Nelson N. Stone, MD, explores the possible applications and current roadblocks of artificial intelligence (AI) and extended reality (XR) for urological training. He begins by outlining the need for more efficient methods of training urologists than training them exclusively on-site.

Dr. Stone discusses issues in traditional surgical training. He notes that the lack of proctors and the OR training model of “education by random opportunity” are not efficient methodologies.

Dr. Stone then outlines a theoretical model, called “Educational System for Instructorless Training” (ESIST), which incorporates XR and AI as an augmentation to proctor guidance during residency training. He acknowledges that neither XR or AI is at the point where they can replace proctors during residency training.

Dr. Stone concludes by presenting a video demonstration of what an ESIST program would look like in practice on a prostate phantom. After the demonstration, he encourages the audience to learn more about advancements in training at the 27th Annual Prostate Cancer Symposium and conducts a brief Q+A with the audience.


About The 34th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 34th iteration of the meeting occurred February 11-14, 2024 in Vail, Colorado. To view more educational presentations from IPCU 34, visit our collection page.


Nelson N. Stone, MD, is Professor of Urology, Radiation Oncology, and Oncological Sciences at the Icahn School of Medicine at Mount Sinai and chief medical officer at Viomerse, Inc.

Dr. Stone earned his medical degree from the University of Maryland in 1979. He completed a Residency in General Surgery in 1981 at the University of Maryland, followed by a Residency in Urology at the University of Maryland. He then completed a Fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center and a Research Fellowship in Biochemical Endocrinology at Rockefeller University in 1986. He was Chief of Urology at Elmhurst Hospital Queens from 1986-1996.

Dr. Stone has founded several medical companies and serves on the editorial board of many scientific journals. He is a member of many professional societies, including the Prostate Conditions Education Council, the Society for Minimally Invasive Therapy, the New York State Urological Society, the American Association of Clinical Urologists, and the American Urologic Association. Dr. Stone has participated in approximately 25 research studies on prostate cancer and has authored more than 500 articles, abstracts, and book chapters, primarily on prostate cancer. He invented the real-time technique for prostate brachytherapy in 1990 and has trained more than 5,000 physicians worldwide through his company ProSeed. His most recent company, Viomerse, creates synthetic body parts (phantoms) for surgical training and has recently released an extended reality remote training platform.